Related Experiment Video
Updated: Jan 3, 2026

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
Published on: May 16, 2022
Calcitonin Gene-Related Peptide (CGRP) Antagonists and Their Use in Migraines
Brianna Henson1, Hanna Hollingsworth1, Erika Nevois1
1Brianna Henson, PharmD, is with PGY-2 Pediatric Pharmacy Resident, Wake Forest Baptist Health Brenner Children's Hospital, Winston-Salem, North Carolina, USA; Hanna Hollingsworth, PharmD, BCPS, is with Pain Clinical Pharmacy Specialist, Parkland Health and Hospital System, Dallas, Texas, USA; Erika Nevois, PharmD, is with CVS/Pharmacy, Springfield, Illinois, USA; Chris Herndon, PharmD, BCACP, is with School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, USA.
Abstract:
Migraine is highly prevalent and associated with a large socio-economic burden in the United States. Current preventive medications have variable efficacy and their use is often limited by intolerable side effects. Calcitonin gene-related peptide (CGRP) has been identified as an integral part of migraine pathophysiology. There are currently seven CGRP antagonists under investigation, all of which are undergoing or have completed phase 3 clinical trials. Three of the investigated CGRP antagonists are approved for use within and outside of the United States. The trials have resulted in positive efficacy and safety data. The purpose of this review is to evaluate the seven CGRP antagonists and their future place in therapy.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antiepileptic Drugs: Glutamate Antagonists
Drugs Acting on Autonomic Ganglia: Blockers
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

